Date: January 30, 2021
Topic: CVR VISION 2021 Clinical Convention
Speakers: Dr. K. Nguyen; Dr. V. Satwah; Dr. N. Morrison; Dr. J. Laredo; Dr. P. Pappas; Dr. M. Gasparis; Dr. Z. Deol; Dr. N. Khilnani; Dr. L. Kelsey; Dr. J. Caprini; Dr. A. Comerota; Dr. S. Vendantham; Dr. K. Gibson; Dr. T. Soto; Dr. G. Lakhanpal; Dr. P. Gagne

Since attending this presentation, participants should be able to: 

  1. Understand the etiology, diagnosis, and clinical presentations of Venous Disease
  2. Evaluate differential diagnosis in patients with multiple symptoms
  3. Learn about current treatment options and disease management
To help assess educational needs, evaluate how we are meeting them, improve the CME program, and meet accreditation standards, please complete the following.

Question Title

* 1. Was it made clear whether or not there was commercial support (sponsorship) for this CME program?

Question Title

* 2. What is your first name?

Question Title

* 3. What is your last name?

Question Title

* 4. What is your email address?

Question Title

* 5. Please list your credentials:

Question Title

* 6. Did the information provided seem biased or compromised by commercial support?

Question Title

* 7. Was disclosure of relevant financial relations provided prior to the presentation?

Question Title

* 8. Were your needs addressed?

Question Title

* 9.  Did this program increase your professional knowledge or skills?

Question Title

* 10. What did you learn?

Question Title

* 11. Will you make any changes in your practice or disease management based on what you learned at this CME activity?

Question Title

* 12. How do you think this will lead to improved health status for patients?

Question Title

* 13. What clinical scenario/challenge will this activity help you address better?

Question Title

* 14. How would you rate the following:

  Poor Fair Excellent No Opinion
Quality of the speaker's presentation
Audio-visual quality and function
Platform for broadcasting (Zoom)
Platform for registration (EventBrite)

Question Title

* 15. Patients who have had iliofemoral DVT treated with anticoagulation

Question Title

* 16. Evidence supports that saphenous ablation reduces the risk of progression to venous ulceration in patients with:

Question Title

* 17. Early intervention for superficial reflux in patients with venous leg ulcers

Question Title

* 18. Which of the following is NOT a design feature of the C-TRACT Clinical Trial?

Question Title

* 19. Please this space to list any additional comments you have about the presenter, material, or platform. 

T